Virtue Diagnostics, Alongside Its Subsidiary Labtest,
Made an Impressive Debut at the 2023 AACC
Date: 2023-07-27
Virtue Diagnostics, together with its fully-owned subsidiary Labtest Diagnostics, one of the largest in vitro diagnostics company in Brazil, participated in the 2023 AACC (American Association for Clinical Chemistry) Annual Scientific Meeting & Clinical Lab Expo, held from July 23 to 27 in California, USA.
During the exhibition, Labtest showcased its brand-new chemiluminesence Immunoassay analyzer(Vercentra CS-1500) and other IVD analyzers, attracting significant number of inquiries and garnering widespread interest from customers in Latin America and the around the globe.
Adhering to the vision of “Focusing on Platform Innovation, Leading Diagnostic Future,” Virtue Diagnostics actively expands its presence in international markets, positioning itself as a frontrunner in the vital emerging markets of in vitro diagnostics.
